Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.
- DOI
- 10.2217/pgs-2021-0028
- Published
- 2021-06-18
- Container
- Pharmacogenomics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2217/pgs-2021-0028,
title = {Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.},
author = {Sahana S and Sivadas A and Mangla M and Jain A and Bhoyar RC and Pandhare K and Mishra A and Sharma D and Imran M and Senthivel V and Divakar MK and Rophina M and Jolly B and Batra A and Sharma S and Siwach S and Jadhao AG and Palande NV and Jha GN and Ashrafi N and Mishra PK and Vidhya AK and Jain S and Dash D and Kumar NS and Vanlallawma A and Sarma RJ and Chhakchhuak L and Kalyanaraman S and Mahadevan R and Kandasamy S and Devi P and Rajagopal RE and Ramya JE and Devi PN and Bajaj A and Gupta V and Mathew S and Goswami S and Prakash S and Joshi K and Kumla M and Sreedevi S and Gajjar D and Soraisham R and Yadav R and Devi YS and Gupta A and Mukerji M and Ramalingam S and Binukumar BK and Sivasubbu S and Scaria V.},
year = {2021},
journal = {Pharmacogenomics},
doi = {10.2217/pgs-2021-0028},
url = {https://doi.org/10.2217/pgs-2021-0028}
}RIS
TY - JOUR TI - Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes. AU - Sahana S AU - Sivadas A AU - Mangla M AU - Jain A AU - Bhoyar RC AU - Pandhare K AU - Mishra A AU - Sharma D AU - Imran M AU - Senthivel V AU - Divakar MK AU - Rophina M AU - Jolly B AU - Batra A AU - Sharma S AU - Siwach S AU - Jadhao AG AU - Palande NV AU - Jha GN AU - Ashrafi N AU - Mishra PK AU - Vidhya AK AU - Jain S AU - Dash D AU - Kumar NS AU - Vanlallawma A AU - Sarma RJ AU - Chhakchhuak L AU - Kalyanaraman S AU - Mahadevan R AU - Kandasamy S AU - Devi P AU - Rajagopal RE AU - Ramya JE AU - Devi PN AU - Bajaj A AU - Gupta V AU - Mathew S AU - Goswami S AU - Prakash S AU - Joshi K AU - Kumla M AU - Sreedevi S AU - Gajjar D AU - Soraisham R AU - Yadav R AU - Devi YS AU - Gupta A AU - Mukerji M AU - Ramalingam S AU - Binukumar BK AU - Sivasubbu S AU - Scaria V. PY - 2021 JO - Pharmacogenomics DO - 10.2217/pgs-2021-0028 UR - https://doi.org/10.2217/pgs-2021-0028 ER -
APA
S, S., A, S., M, M., A, J., RC, B., K, P., A, M., D, S., M, I., V, S., MK, D., M, R., B, J., A, B., S, S., S, S., AG, J., NV, P., GN, J., N, A., PK, M., AK, V., S, J., D, D., NS, K., A, V., RJ, S., L, C., S, K., R, M., S, K., P, D., RE, R., JE, R., PN, D., A, B., V, G., S, M., S, G., S, P., K, J., M, K., S, S., D, G., R, S., R, Y., YS, D., A, G., M, M., S, R., BK, B., S, S., & V., S. (2021). Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.. Pharmacogenomics. https://doi.org/10.2217/pgs-2021-0028
Source records
- europe-pmc · retrieved 2026-09-26T20:36:29.665Z